Screenees: 1027 of 1032 (>99%) colonoscopy screenees who completed both knowledge and attitude items had adequate knowledge; 915 (89%) colonoscopy screenees also had a positive Anti-diabetic Compound Library manufacturer attitude; 815 of 824 (99%) CT colonography screenees who completed both items had adequate knowledge and 742 (90%) also had a positive attitude. Non-screenees: 675 of 698 (97%) colonoscopy non-screenees had adequate knowledge, 344 (49%) also had a negative attitude.

Of the 192 responding CT colonography non-screenees, 180 (94%) had adequate knowledge and 94 (49%) also had a negative attitude. Non-screenees often had adequate knowledge and a positive attitude toward screening: 47% of responding colonoscopy non-screenees (331/698) and 45% of responding CT colonography non-screenees

(86/192). Our study shows that a large majority of colonoscopy and CT colonography screenees make informed decisions about taking part in a population-based colorectal cancer screening program, compared to about half of responding non-screenees. Both in the colonoscopy and in the CT colonography almost half of the responding non-screenees had adequate knowledge and a positive attitude, suggesting the existence Afatinib purchase of additional barriers to participation. Our study has several strengths. Data were collected in a large pilot colorectal cancer screening program, designed as a randomized trial. All invitations were sent in the same time period, minimizing external influences through Proteasome inhibitor general public awareness. The information leaflets of both examinations were identically designed where appropriate and all screenees received a standardized consultation to inform them about the entire screening procedure.

At the time of our study, the Netherlands did not have a population-based colorectal cancer screening program. The decision to participate in a randomized trial, such as this one, differs from the decision to participate in a population-based screening program. It is very well possible that the willingness to participate in a trial does not perfectly translate into the willingness to take part in a more widely announced national screening program. As such, the proportions observed in our study do not unconditionally apply to population-based screening programs in general. We should also mention that the definition of informed decision making as defined by Marteau et al. is not perfect. In decision-making about screening there may be predictable barriers to participation, like expected burden and immobility of an invitee, and unpredictable barriers, such as an acute illness, which might result in differences between intended and actual behavior [37]. We defined adequate knowledge as correct responses to more than half of the knowledge items, an arbitrary cut-off.